Literature DB >> 25797936

Myasthenia Gravis Presenting as Persistent Unilateral Ptosis with Facial Droop.

Sean K Golden1, Chris J Reiff1, Chris J Painter1, Michael D Repplinger1.   

Abstract

BACKGROUND: Myasthenia gravis (MG) is an autoimmune neuromuscular disorder that is classically characterized by fluctuating weakness and fatigability of the ocular, bulbar, limb, or respiratory muscles. Over half of patients with MG will initially experience isolated ocular symptoms in one or both eyes. Most patients report that ocular symptoms are mild or undetectable upon awakening, and worsen throughout the day or with tasks such as driving. We describe an unusual case of MG presenting with an acute onset of persistent unilateral ptosis and ipsilateral facial droop without diurnal variation or other fluctuation in severity. CASE REPORT: A 58-year-old man presented to the Emergency Department with a 3-day history of persistent, unilateral ptosis with facial droop, concerning for stroke. However, magnetic resonance imaging of the head found no evidence of stroke or any other central etiology. Routine laboratory testing was unremarkable. Neurology was consulted and they recommended sending acetylcholine receptor antibody tests. At the patient's subsequent neurology clinic visit, these tests were found to be abnormal. Electromyography was also done at this visit, confirming the diagnosis of MG. The patient subsequently underwent thymectomy and immunosuppressive therapy, with great improvement in his symptoms. WHY SHOULD AN EMERGENCY PHYSICIAN BE AWARE OF THIS?: MG may present as unilateral ptosis or facial drooping without the hallmark characteristic of fluctuating muscle weakness. Early diagnosis and subsequent treatment of MG improves long-term prognosis and remission rates. Emergency physicians should consider myasthenia gravis in cases of unilateral ocular symptoms after ruling out emergent central etiologies.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  facial weakness; myasthenia gravis; ptosis; stroke

Mesh:

Year:  2015        PMID: 25797936      PMCID: PMC4476909          DOI: 10.1016/j.jemermed.2015.01.002

Source DB:  PubMed          Journal:  J Emerg Med        ISSN: 0736-4679            Impact factor:   1.484


  23 in total

1.  Myasthenic crisis presenting as isolated vocal cord paralysis.

Authors:  P B Cridge; J Allegra; H Gerhard
Journal:  Am J Emerg Med       Date:  2000-03       Impact factor: 2.469

Review 2.  Lifetime course of myasthenia gravis.

Authors:  David Grob; Norman Brunner; Tatsuji Namba; Murali Pagala
Journal:  Muscle Nerve       Date:  2008-02       Impact factor: 3.217

3.  A cause of reversible dysphagia: an unusual presentation of myasthenia gravis.

Authors:  J M Brostoff; D Dahdaleh; J Birns
Journal:  Eur J Intern Med       Date:  2007-08-10       Impact factor: 4.487

4.  Long-term administration of corticosteroids in myasthenia gravis.

Authors:  J D Mann; T R Johns; J F Campa
Journal:  Neurology       Date:  1976-08       Impact factor: 9.910

Review 5.  The course of myasthenia gravis and therapies affecting outcome.

Authors:  D Grob; E L Arsura; N G Brunner; T Namba
Journal:  Ann N Y Acad Sci       Date:  1987       Impact factor: 5.691

Review 6.  Corticosteroids for myasthenia gravis.

Authors:  C Schneider-Gold; P Gajdos; K V Toyka; R R Hohlfeld
Journal:  Cochrane Database Syst Rev       Date:  2005-04-18

7.  Non-ptotic ocular myasthenia gravis: a common presentation of an uncommon disease.

Authors:  Jennifer Colavito; Jeffrey Cooper; Kenneth J Ciuffreda
Journal:  Optometry       Date:  2005-07

8.  Thyroid function and circulating antithyroid antibodies in myasthenia gravis.

Authors:  W R Kiessling; K W Pflughaupt; K Ricker; I Haubitz; H G Mertens
Journal:  Neurology       Date:  1981-06       Impact factor: 9.910

9.  Incidence and mortality rates of myasthenia gravis and myasthenic crisis in US hospitals.

Authors:  A Alshekhlee; J D Miles; B Katirji; D C Preston; H J Kaminski
Journal:  Neurology       Date:  2009-05-05       Impact factor: 9.910

10.  Myasthenia gravis: a review of available treatment approaches.

Authors:  Nils Erik Gilhus; Jone F Owe; Jana Midelfart Hoff; Fredrik Romi; Geir Olve Skeie; Johan A Aarli
Journal:  Autoimmune Dis       Date:  2011-10-05
View more
  1 in total

1.  Myasthenic Crisis In Pregnancy.

Authors:  David M French; E Page Bridges; Matthew C Hoskins; Charles M Andrews; Cecil H Nelson
Journal:  Clin Pract Cases Emerg Med       Date:  2017-10-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.